Jennifer Johnson joins HaydenCG as Principal
Hayden Consulting Group is pleased to announce that Jennifer Johnson has joined the firm as Principal. Welcome to HaydenCG, Jenn. We’re thrilled to have you aboard!
May 9, 2022 - Boston, MA
Hayden Consulting Group, the BioPharma industry’s premier consultancy focused on strategy and analytics for Commercialization and Market Access, has welcomed Jennifer Johnson to the firm as Principal.
Jennifer joins HaydenCG with extensive BioPharma consulting experience and is passionate about using data-driven approaches to help pharmaceutical clients compete in today’s increasingly value-based market. She is well versed in using a mix of approaches to best answer key business questions and particularly enjoys collaborating with clients to tackle tough goals. With experience in both patient support program operations and design, Jennifer is acutely aware that real-world patient and provider access are key to commercial success and long-term viability for brands launching in the US.
Just prior to joining HaydenCG, Jennifer volunteered with COVID-19 vaccination efforts among California’s marginalized communities and previously held positions at Charles River Associates, IQVIA, and AmerisourceBergen. Jennifer joins the HaydenCG senior leadership team and is looking forward to delivering the unparalleled value and expertise clients have come to expect from HaydenCG.
“I have always been impressed by the scientific innovation in our industry and am excited about the promise of personalized medicine to transform lives,” Jennifer shares. “I sometimes worry, however, that these new treatments could exacerbate existing systemic health inequities along with the other challenges our industry faces. It takes not only clients asking the right questions but a consultative team willing to approach old problems with new ideas. ‘Seek adventure’ and ‘do the right thing’ are two of Hayden’s core values and having worked with the leadership team previously in my career, I know this team embraces a good challenge. To be part of that is truly special.”
About Hayden Consulting Group:
Hayden Consulting Group, founded in 2019, is the Life Science industry's premier Market Access and Commercialization strategic consultancy. Our singular focus is to deliver game-changing analytical and strategic guidance to radically transform the commercial trajectory of therapies, portfolios, and entire companies. We were founded to provide the BioPharma industry with needed expertise to solve the most pressing Access, Reimbursement, Policy, and Commercialization challenges in today's marketplace. Our services are designed to create competitive advantages, build strong analytical foundations, and turbo-charge growth plans. Nothing is cookie-cutter. The only common theme in what we do is 100% focus on our clients’ success. Follow us on LinkedIn